RWM
EDIT icon

Rialto Wealth Management’s Editas Medicine EDIT Stock Holding History

Rialto Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Hold
325
– – ﹤0.01% 1358
2026
Q1 		$803 Hold
325
– – ﹤0.01% 1188
2025
Q4 		$667 Hold
325
– – ﹤0.01% 1137
2025
Q3 		$1.13K Hold
325
– – ﹤0.01% 890
2025
Q2 		$715 Buy
+325
New +$532 ﹤0.01% 982

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rialto Wealth Management's EDIT Position: Q2 2026 in Review

Rialto Wealth Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 325 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Rialto Wealth Management first reported a position in EDIT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.13K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Rialto Wealth Management held 325 shares of Editas Medicine worth $1.05K as of Q2 2026.
  • Rialto Wealth Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1358 holding.
  • Rialto Wealth Management first reported a position in Editas Medicine in Q2 2025 and has held it in 5 quarters since.
  • Rialto Wealth Management's Editas Medicine position peaked at $1.13K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.